Top Story

Almost 16% of pediatric transplant recipients hospitalized with vaccine-preventable diseases

January 15, 2019
In the Journals

Nurse-led HCV care model results in 95% or higher SVR rates in prison

January 15, 2019
A decentralized, nurse-led model of hepatitis C care with direct-acting antivirals was significantly effective and led to high levels of sustained virologic response in…
FDA News

FDA approves Cabometyx for treatment-experienced patients with HCC

January 15, 2019
Exelixis has announced it has received FDA approval for Cabometyx to treat patients with hepatocellular carcinoma who previously underwent treatment with Nexavar…
In the Journals

Stress, environment key barriers to Mediterranean diet uptake for NAFLD

January 14, 2019
Barriers to initiating a Mediterranean diet — shown to improve liver health in patients with nonalcoholic fatty liver disease — included an obesogenic…

ChemomAb doses first patient in phase 1 NAFLD trial

January 14, 2019
ChemomAb dosed the first patient in a phase 1b repeated-dose clinical trial of CM-101 for treating patients with nonalcoholic fatty liver disease and nonalcoholic…
More Headlines »

Cirrhosis and Hepatic Encephalopathy – Managing Their Consequences and Complications

This activity is supported by an educational grant from Salix Pharmaceuticals, a division of Valeant Pharmaceuticals North America LLC.

Cirrhosis, or advanced fibrosis of the liver, can lead to serious health sequelae or death. However, substantial…
More »
GI Bookshelf

Question 28: I Have A Patient With Biliary-Type Pain, But No Other Evidence Of Bile Duct Disease (Normal Diameter Duct On Ultrasound, Normal Liver Function Tests). How Should Such A Patient Be Managed?

From Curbside Consultation in Endoscopy: 49 Clinical Questions, Second Edition
More »
Resource Centers
International Liver Congress

International Liver Congress

Meeting News

VIDEO: Acute intermittent porphyria therapeutic progresses to phase 3

November 12, 2018
More »
Current Issues Current Issues
View the Current Issue
HCV Next